The FDA criticized the maker of Ozempic and Wegovy, Novo Nordisk, for “serious violations” related to the reporting of possible side effects linked to semaglutide, the active ingredient in the drug. NBC News’ Emily Lorsch reports on the GLP-1 drugs.
For more context and news coverage of the most important stories of our day, click here:
» Subscribe to NBC News:
» Subscribe to Here’s the Scoop podcast:
Every day, NBC News helps people understand what’s happening and why it matters — through fact-based reporting, meaningful conversations, and powerful stories. From its leading news broadcasts — TODAY, NBC Nightly News, Meet the Press, and Dateline — to NBC News NOW, the 24/7 streaming news channel, plus chart-topping podcasts, the NBC News app, and NBCNews.com, NBC News keeps audiences informed and connected to the stories shaping our world.
Connect with NBC News Online!
NBC News App:
Breaking News Alerts:
Visit NBCNews.Com:
Find NBC News on Facebook:
Follow NBC News on Twitter:
Follow NBC News on Instagram:
#Ozempic #drug #health
source
